SCHEMBL5222924

SCHEMBL5222924

O=C(O)NC1(Cc2cccc(Cl)c2)CCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.46
ALDH1A1 P00352 4/20 0.44
ADRB2 P07550 2/20 0.44
HTT P42858 1/20 0.44
EPHX2 P34913 1/20 0.44
CTBP2 P56545 1/20 0.42
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TAAR1 Q96RJ0 2/20 0.41
RXFP1 Q9HBX9 1/20 0.41
GLA P06280 1/20 0.41
SSTR1 P30872 1/20 0.41
SSTR4 P31391 1/20 0.41
METAP2 P50579 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM3 P20309 1/20 0.40
HCRTR1 O43613 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3717417 0.83 ADRB2 (0.58) HSD11B1ALDH1A1ADRB2HTTHPGD
SCHEMBL3618445 0.79 ADRB2 (0.65) ALDH1A1ADRB2HTTEPHX2KMT2A
SCHEMBL5220049 0.78 L3MBTL1 (0.49) HSD11B1ALDH1A1EPHX2CTBP2KMT2A
SCHEMBL5913507 0.77 MAOA (0.42) HSD11B1ALDH1A1ADRB2HTT
SCHEMBL21826102 0.75 L3MBTL1 (0.49) HSD11B1ALDH1A1EPHX2CTBP2KMT2A
SCHEMBL30601825 0.74 HSD11B1 (0.51) HSD11B1ALDH1A1EPHX2CTBP2KMT2A
SCHEMBL26123313 0.74 HSD11B1 (0.51) HSD11B1ALDH1A1EPHX2CTBP2KMT2A
SCHEMBL12821484 0.73 ADRB2 (0.58) ALDH1A1ADRB2HTTEPHX2HPGD
SCHEMBL25518220 0.73 PNMT (0.46) HSD11B1EPHX2KMT2AMEN1TAAR1
SCHEMBL20482850 0.72 ALDH1A1 (0.51) ALDH1A1EPHX2KMT2AMEN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed
EP-1567488-A1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LIMITED (GB) 2005-08-31 EP disclosed
WO-2004050619-A1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LIMITED (GB) 2004-06-17 WO disclosed